Gurnee, IL, United States of America

Leping Li


Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 101(Granted Patents)


Location History:

  • Gurnee, IL (US) (1995 - 2000)
  • Foster City, CA (US) (2000)

Company Filing History:


Years Active: 1995-2000

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Leping Li: Pioneering Innovations in Antibacterial Compounds

Introduction:

In the bustling tech landscape of Gurnee, IL stands a standout inventor, Leping Li, whose dedication to innovation has positioned him as a prominent figure in the field. With a promising future ahead, Li has made remarkable contributions, particularly in the realm of antibacterial compounds.

Latest Patents:

Leping Li holds an impressive portfolio of 5 patents, showcasing his expertise in the development of cutting-edge solutions. His latest patents include "6-O-substituted erythromycin compounds and method for making same" and "6,11-bridged erythromycin derivatives", which highlight his focus on antimicrobial advancements.

Career Highlights:

Currently employed at Abbott Laboratories Corporation, Li continues to push boundaries in the development of pharmaceutical innovations. His role at Abbott Labs has allowed him to spearhead groundbreaking research and further solidify his reputation as an esteemed inventor in the industry.

Collaborations:

Alongside notable coworkers Larry L Klein and Clinton M Yeung, Leping Li has engaged in collaborative efforts aimed at revolutionizing the field of antibacterial compounds. Together, they have synergized their expertise to drive innovation and fuel advancements that benefit society as a whole.

Conclusion:

In conclusion, Leping Li's visionary approach to invention and his unwavering commitment to innovation have established him as a true trailblazer in the technological landscape. With a rich tapestry of patents under his belt and a bright future ahead at Abbott Laboratories Corporation, Li's contributions continue to shape the future of antibacterial research and pharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…